IEG Vu is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ocean Nutrition Omega 3 deal

This article was originally published in Foodnews

OCEAN Nutrition Canada, the world's largest Omega-3 EPA/DHA solutions provider, has signed a long-term joint venture with Wilmar International, Asia's leading agribusiness and a global leader in Omega-3 foods. The collaboration has resulted in the launch of Wilmar's new Arawana 3A+ premium cooking oil which offers the added health benefits of Omega-3 EPA/DHA, sourced from MEG-3 fish oil. "Partnering with Ocean Nutrition Canada is strategically important because they offer not only the most highly trusted source of Omega-3 EPA/DHA, but also superior service, and on-going support," said Lee Hock Kuan, chairman of Yihai Kerry Foodstuffs Marketing Co, a wholly-owned subsidiary of Wilmar International. "We continue to invest and expand our manufacturing and distribution infrastructure, and this alliance is a significant long-term exciting endeavour for both parties." According to a national survey conducted by the Ministry of Health of the People's Republic of China, the average daily intake of EPA/DHA of Chinese residents is only 37.6 mg/day – less than 25% of the level accepted by the United States Institute of Medicine. Due to this deficiency in the Chinese diet, Wilmar, in association with the Chinese Nutrition Society, is launching Arawana 3A+ which is a blended vegetable oil product that contains sufficient Omega-3 to help Chinese consumers meet IOM Omega-3 intake recommendations. EPA and DHA are important nutrients that help support and maintain the normal function of the brain, heart, and body.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

CO015695

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel